Clostridium sporogenesdelivers interleukin-12 to hypoxic tumours, producing antitumour activity without significant toxicity

Tumor-colonizing bacteria: A potential tumor targeting therapy

(2013) Chao Zu et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Local secretion of IL-12 augments the therapeutic impact of dendritic cell–tumor cell fusion vaccination

(2013) Chunrui Tan et al.   JOURNAL OF SURGICAL RESEARCH

Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas

(2013) Sid P Kerkar et al.   MOLECULAR THERAPY

The impact of intraoperative vaccination with IL-12 modified autologous tumor cells in the Lewis lung carcinoma mouse model

(2012) Arne Dietrich et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma

(2011) Darja Pavlin et al.   CANCER BIOLOGY & THERAPY

The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity

(2011) S H Seo et al.   GENE THERAPY

Interleukin-12 Gene Modification Exerts Anti-Tumor Effects on Murine Mammary Sarcoma Cell Line in vivo

(2010) Dan Li et al.   Cellular & Molecular Immunology

IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms

(2010) Elizabeth W. Sorensen et al.   JOURNAL OF IMMUNOLOGY

Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12

(2010) David A. Zaharoff et al.   JOURNAL OF IMMUNOTHERAPY

IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments

(2009) Michelle R. Simpson-Abelson et al.   CLINICAL IMMUNOLOGY

Optimized Clostridium-Directed Enzyme Prodrug Therapy Improves the Antitumor Activity of the Novel DNA Cross-Linking Agent PR-104

(2008) S.-C. Liu et al.   CANCER RESEARCH